NCT04273243View on ClinicalTrials.gov

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 24, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

CLN6Batten Disease

Interventions

GENETIC

AT-GTX-501

No study drug is administered in this study. Subjects who received AT-GTX-501 in a previous trial will be evaluated in this trial for long-term safety and efficacy.

Trial Locations (1)

43205

Nationwide Children's Hosptial, Columbus

All Listed Sponsors

lead

Emily de los Reyes

OTHER

NCT04273243 - Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer | Biotech Hunter | Biotech Hunter